Collaboration Will Endeavor to Reach Millions Suffering from Undiagnosed and Untreated Sleep Apnea Sufferers
Itamar Medical and SoClean Inc. today announced a collaboration agreement between their respective wholly-owned subsidiaries to make Itamar Medical’s WatchPAT ONE home sleep apnea test and Digital Health Services available to consumers. The collaboration is designed to overcome the barriers to sleep apnea testing and therapy solutions by enabling consumers to purchase remote sleep consultations and home-based sleep testing using the WatchPAT ONE in the comfort of their own homes.
WatchPAT ONE is the first and only disposable home sleep apnea test (HSAT) cleared by the FDA. WatchPAT ONE provides an automated and comprehensive sleep report for interpretation and is simple to use with logistical advantages that are uniquely suited to the DTC market.
Under the terms of the collaboration agreement, SoClean’s Subsidiary (“SoClean”) will have exclusivity to market and sell the WatchPAT ONE to the DTC Segment in the United States, subject to purchasing certain minimum quantities. SoClean will have exclusive DTC rights in the U.S. through any and all marketing and sales channels, excluding healthcare providers and facilities and SoClean’s parent company, has agreed to guarantee the performance of the collaboration by its subsidiary. SoClean plans to announce further details regarding its home sleep apnea testing service in Q1 2020.
Source: Itamar Medical